Literature DB >> 10781016

CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues.

P Chakravarty1, T P Suthar, H A Coppock, C G Nicholl, S R Bloom, S Legon, D M Smith.   

Abstract

1. Putative receptors for CGRP and adrenomedullin have been investigated in the rat. Calcitonin Receptor-Like Receptor (CRLR), in combination with Receptor Activity Modifying Proteins (RAMPs) is hypothesized to bind either CGRP or adrenomedullin. The receptors known as RDC1 and L1 have also been shown to bind CGRP and adrenomedullin respectively. 2. In this study it is shown that rat CRLR cDNA specifies a CGRP receptor when co-transfected with RAMP-1 cDNA and an adrenomedullin receptor when co-transfected with either RAMP-2 or RAMP-3 cDNA in human embryonic kidney 293 cells. 3. CRLR, RAMP, RCD1 and L1 mRNA levels and CGRP and adrenomedullin receptor densities have been measured and correlated with each other in eight rat tissues selected for their distinctive patterns of CGRP and adrenomedullin binding. 4. The data are consistent with the predictions of the CRLR/RAMP model. CGRP binding correlates well with RAMP-1 mRNA levels (R=1.0, P=0.007), adrenomedullin binding shows a tendency to vary with RAMP-2 mRNA levels (R=0.85, P=0.14) and total binding is correlated with CRLR mRNA levels (R=0.94, P=0.03). The data do not support the hypothesis that RDC1 and L1 account for the majority of CGRP and adrenomedullin binding respectively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781016      PMCID: PMC1572027          DOI: 10.1038/sj.bjp.0702975

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Cross-reactivity of amylin with calcitonin-gene-related peptide binding sites in rat liver and skeletal muscle membranes.

Authors:  A Chantry; B Leighton; A J Day
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

2.  A new calcitonin-receptor-like sequence in rat pulmonary blood vessels.

Authors:  F Njuki; C G Nicholl; A Howard; J C Mak; P J Barnes; S I Girgis; S Legon
Journal:  Clin Sci (Lond)       Date:  1993-10       Impact factor: 6.124

3.  Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain.

Authors:  C P Chang; R V Pearse; S O'Connell; M G Rosenfeld
Journal:  Neuron       Date:  1993-12       Impact factor: 17.173

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.

Authors:  G Christopoulos; K J Perry; M Morfis; N Tilakaratne; Y Gao; N J Fraser; M J Main; S M Foord; P M Sexton
Journal:  Mol Pharmacol       Date:  1999-07       Impact factor: 4.436

6.  Molecular identification of binding sites for calcitonin gene-related peptide (CGRP) and islet amyloid polypeptide (IAPP) in mammalian lung: species variation and binding of truncated CGRP and IAPP.

Authors:  R Bhogal; D M Smith; P Purkiss; S R Bloom
Journal:  Endocrinology       Date:  1993-11       Impact factor: 4.736

7.  Expression cloning of an adenylate cyclase-coupled calcitonin receptor.

Authors:  H Y Lin; T L Harris; M S Flannery; A Aruffo; E H Kaji; A Gorn; L F Kolakowski; H F Lodish; S R Goldring
Journal:  Science       Date:  1991-11-15       Impact factor: 47.728

8.  Characterization of rat gastric inhibitory peptide cDNA.

Authors:  S K Sharma; C Austin; A Howard; G Lo; C G Nicholl; S Legon
Journal:  J Mol Endocrinol       Date:  1992-12       Impact factor: 5.098

9.  Photoaffinity labeling of rat calcitonin gene-related peptide receptors and adenylate cyclase activation: identification of receptor subtypes.

Authors:  D Stangl; R Muff; C Schmolck; J A Fischer
Journal:  Endocrinology       Date:  1993-02       Impact factor: 4.736

10.  Investigation and characterization of binding sites for islet amyloid polypeptide in rat membranes.

Authors:  R Bhogal; D M Smith; S R Bloom
Journal:  Endocrinology       Date:  1992-02       Impact factor: 4.736

View more
  21 in total

Review 1.  The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors.

Authors:  Debbie L Hay; Alex C Conner; Stephen G Howitt; David M Smith; David R Poyner
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 2.  New methods for researching accessory proteins.

Authors:  Steven M Foord; Simon D Topp; Marco Abramo; Joanna D Holbrook
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

3.  Effect of Valsartan on Cerebellar Adrenomedullin System Dysregulation During Hypertension.

Authors:  Leticia Figueira; Anita Israel
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

4.  Adrenomedullin, a neuropeptide with immunoregulatory properties induces semi-mature tolerogenic dendritic cells.

Authors:  Sandrine Rullé; Marie-Dominique Ah Kioon; Carine Asensio; Julie Mussard; Hang-Korng Ea; Marie-Christophe Boissier; Frédéric Lioté; Géraldine Falgarone
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

Review 5.  Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine.

Authors:  Eric L Moore; Christopher A Salvatore
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 6.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

7.  CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS.

Authors:  D L Hay; S G Howitt; A C Conner; M Schindler; D M Smith; D R Poyner
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

8.  Decrease in arterial pressure induced by adrenomedullin in the hypothalamic paraventricular nucleus is mediated by nitric oxide and GABA.

Authors:  Yong Xu; Teresa L Krukoff
Journal:  Regul Pept       Date:  2004-06-15

9.  Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines.

Authors:  Tejal Choksi; Debbie L Hay; Stephen Legon; David R Poyner; Stefanie Hagner; Stephen R Bloom; David M Smith
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

10.  Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability.

Authors:  Uwe Pfeil; Muhammad Aslam; Renate Paddenberg; Karin Quanz; Chia L Chang; Jae-Il Park; Barbara Gries; Amir Rafiq; Petra Faulhammer; Anna Goldenberg; Tamara Papadakis; Thomas Noll; Sheau Y T Hsu; Norbert Weissmann; Wolfgang Kummer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-14       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.